Agree with Percy's comments, Lainy. We can always count on you being here for us. You are appreciated by us all, but then you already know that. Thank you, dear Lainy.
In re: to the above mentioned article I would like to comment on the fact that our cancer lacks the molecular understanding of the disease something, we, the foundation, are focusing on.
Secondly, it is important to understand the meaning of a Phase I clinical trial.
"The patients in Phase I trials, which test brand new drugs for safety and dosage rather than efficacy, are usually in a bad place. Their cancers are advanced, and they’ve already had lots of treatments. In short, they’re dying. They’re willing to be guinea pigs on the off-chance that something new might buy them some time.
Traditionally, “there was no particular expectation that you would even see any responses in a Phase I setting,” says George Sledge, a professor at the Indiana University School of Medicine and the former president of the American Society of Clinical Oncology.
THIS INFORMATION IS NOT INTENDED NOR IMPLIED TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE. YOU SHOULD ALWAYS SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROVIDER